GeneDx Holdings (WGS) Free Cash Flow Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | -585.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -585.59% |
| Mar 31, 2026 | -1,045.55% |
| Dec 31, 2025 | 465.53% |
| Sep 30, 2025 | 247.48% |
| Jun 30, 2025 | 276.44% |
| Mar 31, 2025 | 124.04% |
| Dec 31, 2024 | 88.99% |
| Sep 30, 2024 | 83.61% |
| Jun 30, 2024 | 91.89% |
| Mar 31, 2024 | 69.66% |
| Dec 31, 2023 | 59.05% |
| Sep 30, 2023 | 54.47% |
| Jun 30, 2023 | 34.59% |
| Mar 31, 2023 | 32.96% |
| Dec 31, 2022 | -59.70% |
| Sep 30, 2022 | -18.53% |
| Jun 30, 2022 | -192.76% |
| Mar 31, 2022 | -87.14% |
| Dec 31, 2021 | -7,685.62% |
| Sep 30, 2021 | -20,001.80% |